Pharma Mar SA (PHM)

Track

Over the past 90 days, Pharma Mar SA has seen two insider buy transactions totaling approximately 149,652 EUR. These purchases were made by board members, with no executive-level selling reported during this period. The stock has experienced a 21% decline over the last three months, currently trading at 36.53% of its 52-week range.

Recent historical selling signal · Apr 2026

Top insider buys (90, 60d)

Top cluster buys (90, 60d)

Featured in screeners

Recent historical selling signal · Apr 2026

Top insider buys

Top cluster buys

Ticker: PHM Exchange: MCE

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signal detected

15 activity signals detected for Pharma Mar SA

Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Pharma Mar SA. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Buy 16 Jun 2026

Value €2,717,538.85 | Price 168.32 | Shares 82,906

Buy 12 Jun 2026

Value €3,744,343.55 | Price 76.12 | Shares 21,433

Buy 21 Apr 2026

Value €93,620.00 | Price 93.62 | Shares 1,000

Sale 10 Apr 2026

Value €19,777.03 | Price 93.73 | Shares 211

Sale 10 Apr 2026

Value €20,460.00 | Price 93.00 | Shares 220

Sale 27 Mar 2026

Value €73,395.50 | Price 90.50 | Shares 811

Buy 26 Mar 2026

Value €11,909.22 | Price 81.57 | Shares 146

Buy 23 Mar 2026

Value €8,100.00 | Price 81.00 | Shares 100

Sale 17 Mar 2026

Value €6,600.00 | Price 88.00 | Shares 75

Buy 12 Mar 2026

Value €6,075.00 | Price 81.00 | Shares 75

Buy 6 Nov 2025

Value €5,061.00 | Price 72.30 | Shares 70

Buy 24 Oct 2025

Value €37,285.00 | Price 74.57 | Shares 500

Buy 23 Oct 2025

Value €7,635.00 | Price 76.35 | Shares 100

Buy 7 Oct 2025

Value €18,920.00 | Price 88.00 | Shares 215

Sale 17 Sep 2025

Value €19,780.00 | Price 92.00 | Shares 215

Buy 6 Jun 2025

Value €8,310.00 | Price 83.10 | Shares 100

Buy 6 Jun 2025

Value €8,381.00 | Price 83.81 | Shares 100

Buy 3 Jun 2025

Value €8,951.00 | Price 89.51 | Shares 100

Buy 2 Jun 2025

Value €8,760.00 | Price 87.60 | Shares 100

Buy 20 May 2025

Value €199,486.10 | Price 83.05 | Shares 2,402

Through EDUARDO SERRA Y ASOCIADOS, S.L., a closely affiliated person

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-06-17	2026-06-16	B Purchase	2.6 SOLEDAD CUENCA MIRANDA CONSEJERA Director	82,906 168.32 €2,717,539	82,906	168.32	€2,717,539
2026-06-15	2026-06-12	B Purchase	2.4 MONTSERRAT ANDRADE DETRELL CONSEJERA Director	21,433 76.12 €3,744,344	21,433	76.12	€3,744,344
2026-04-22	2026-04-21	B Purchase	2.6 JOSÉ MARÍA FERNÁNDEZ SOUSA-FARO CONSEJERO (PRESIDENTE) Director	50,040 48.25 €4,576,394	50,040	48.25	€4,576,394
2026-04-10	2026-04-10	S Sale	INÉS PÉREZ CALLEJA DIRECTORA DE CALIDAD Officer	211 93.73 €19,777	211	93.73	€19,777
2026-04-10	2026-04-10	S Sale	2.1 MARÍA CONCEPCIÓN SANZ LÓPEZ DIRECTORA LEGAL DE NEGOCIO Officer	220 93.00 €20,460	220	93.00	€20,460
2026-04-06	2026-03-27	S Sale	2.4 LUIS MORA CAPITÁN DIRECTOR GENERAL UNIDAD DE NEGOCIO DE ONCOLOGÍA Officer	811 90.50 €73,396	811	90.50	€73,396
2026-04-06	2026-03-26	B Purchase	2.4 LUIS MORA CAPITÁN DIRECTOR GENERAL UNIDAD DE NEGOCIO DE ONCOLOGÍA Officer	146 81.57 €11,909	146	81.57	€11,909
2026-03-24	2026-03-23	B Purchase	2.6 SOLEDAD CUENCA MIRANDA CONSEJERA Director	100 81.00 €8,100	100	81.00	€8,100
2026-03-19	2026-03-17	S Sale	2.6 SOLEDAD CUENCA MIRANDA CONSEJERA Director	75 88.00 €6,600	75	88.00	€6,600
2026-03-16	2026-03-12	B Purchase	2.6 SOLEDAD CUENCA MIRANDA CONSEJERA Director	75 81.00 €6,075	75	81.00	€6,075
2025-11-11	2025-11-06	B Purchase	2.6 SOLEDAD CUENCA MIRANDA CONSEJERA Director	70 72.30 €5,061	70	72.30	€5,061
2025-10-24	2025-10-24	B Purchase	2.8 FERNANDO MARTÍN-DELGADO SANTOS CONSEJERO Director	500 74.57 €37,285	500	74.57	€37,285
2025-10-28	2025-10-23	B Purchase	2.8 ROSA MARÍA SÁNCHEZ-YEBRA ALONSO CONSEJERA Director	100 76.35 €7,635	100	76.35	€7,635
2025-10-08	2025-10-07	B Purchase	2.6 SOLEDAD CUENCA MIRANDA CONSEJERA Director	215 88.00 €18,920	215	88.00	€18,920
2025-09-22	2025-09-17	S Sale	2.6 SOLEDAD CUENCA MIRANDA CONSEJERA Director	215 92.00 €19,780	215	92.00	€19,780
2025-06-09	2025-06-06	B Purchase	2.8 ROSA MARÍA SÁNCHEZ-YEBRA ALONSO CONSEJERA Director	100 83.10 €8,310	100	83.10	€8,310
2025-06-09	2025-06-06	B Purchase	2.8 FERNANDO MARTÍN-DELGADO SANTOS CONSEJERO Director	100 83.81 €8,381	100	83.81	€8,381
2025-06-05	2025-06-03	B Purchase	2.8 ROSA MARÍA SÁNCHEZ-YEBRA ALONSO CONSEJERA Director	100 89.51 €8,951	100	89.51	€8,951
2025-06-05	2025-06-02	B Purchase	2.8 ROSA MARÍA SÁNCHEZ-YEBRA ALONSO CONSEJERA Director	100 87.60 €8,760	100	87.60	€8,760
2025-05-22	2025-05-20	B Purchase	2.2 EDUARDO SERRA REXACH (CONSEJERO) Through EDUARDO SERRA Y ASOCIADOS, S.L., a closely affiliated person Director	2,402 83.05 €199,486	2,402	83.05	€199,486

Explore more

More insider trading research around Pharma Mar SA

More insider trades in Spain

Similar Healthcare companies with insider activity

More Pharmaceuticals & Medical Research companies with insider activity

More Pharmaceuticals companies with insider activity

Insider trading in Europe

Pharma Mar SA (PHM)

Track

Featured in screeners

Upgrade for signal details

Transactions

Insider

Sort by

Trades

Explore more